The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and immunobiological activity of guadecitabine sequenced with ipilimumab in metastatic melanoma patients: The phase Ib NIBIT-M4 study.
 
Anna Maria Di Giacomo
Consulting or Advisory Role - GlaxoSmithKline; Incyte; Pierre Fabre
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Alessia Covre
No Relationships to Disclose
 
Francesca Finotello
No Relationships to Disclose
 
Dietmar Rieder
No Relationships to Disclose
 
Luca Sigalotti
No Relationships to Disclose
 
Diana Giannarelli
No Relationships to Disclose
 
Florent Petitprez
No Relationships to Disclose
 
Laetitia Lacroix
No Relationships to Disclose
 
Ornella Cutaia
No Relationships to Disclose
 
Carolina Fazio
No Relationships to Disclose
 
Sandra Coral
No Relationships to Disclose
 
Andrea Anichini
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst)
 
Christoph Bock
Speakers' Bureau - Bayer Holding; Boehringer Ingelheim
 
James N. Lowder
Employment - Astex Pharmaceuticals
 
Mohammad Azab
Employment - Astex Pharmaceuticals
 
Wolf-Herman Fridman
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - MedImmune; Novartis; Pierre Fabre; SERVIER
Patents, Royalties, Other Intellectual Property - HalioDx
 
Catherine Sautes-Fridman
Research Funding - Pierre Fabre (Inst)
 
Zlatko Trajanoski
Consulting or Advisory Role - Merck
Speakers' Bureau - Roche
 
Michele Maio
Stock and Other Ownership Interests - Theravance
Honoraria - Alfasigma; Amgen; AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pierre Fabre; Roche
Consulting or Advisory Role - Alfasigma; AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pierre Fabre; Roche
Patents, Royalties, Other Intellectual Property - DNA Hypomethylating agents for cancer therapy
Travel, Accommodations, Expenses - Alfasigma; Amgen; AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pierre Fabre; Roche